Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Archives of Internal Medicine
|
December 1, 1992
Carbamazepine neurotoxic reaction after administration of diltiazem
E Maoz, E Grossman, M Thaler, et al.
Journal of Hypertension
|
September 1, 1992
The role of atrial natriuretic peptide in natriuresis of fasting
E Maoz, A Shamiss, E Peleg, et al.
Postgraduate Medical Journal
|
February 2, 1999
Cytomegalovirus infection associated with ulcerative colitis in immunocompetent individuals
C Rachima, E Maoz, S Apter, et al.
Helicobacter
|
June 26, 1999
Seroprevalence of Helicobacter pylori and length of stay in a nursing home
A Regev, G M Fraser, M Braun, et al.
Journal of Clinical Gastroenterology
|
December 17, 1998
A comparison of new rapid urease tests for detection of Helicobacter pylori: test characteristics and factors affecting positivity and time to positivity
Y Niv, A D Sperber, E Scapa, et al.
Alimentary Pharmacology & Therapeutics
|
November 28, 2008
Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms
P Rozen, Z Levi, R Hazazi, et al.
The American Journal of Gastroenterology
|
September 11, 1998
Comparison of two bowel preparations for colonoscopy: sodium picosulphate with magnesium citrate versus sulphate-free polyethylene glycol lavage solution
A Regev, G Fraser, G Delpre, et al.
Alimentary Pharmacology & Therapeutics
|
October 13, 2006
Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Z Levi, P Rozen, R Hazazi, et al.
Alimentary Pharmacology & Therapeutics
|
February 3, 2009
Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed
P Rozen, Z Levi, R Hazazi, et al.
Alimentary Pharmacology & Therapeutics
|
November 21, 2009
Can patients at high risk for significant colorectal neoplasms and having normal quantitative faecal occult blood test postpone elective colonoscopy?
R Hazazi, P Rozen, M Leshno, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Archives of Internal Medicine
|
December 1, 1992
Carbamazepine neurotoxic reaction after administration of diltiazem
E Maoz, E Grossman, M Thaler, et al.
Journal of Hypertension
|
September 1, 1992
The role of atrial natriuretic peptide in natriuresis of fasting
E Maoz, A Shamiss, E Peleg, et al.
Postgraduate Medical Journal
|
February 2, 1999
Cytomegalovirus infection associated with ulcerative colitis in immunocompetent individuals
C Rachima, E Maoz, S Apter, et al.
Helicobacter
|
June 26, 1999
Seroprevalence of Helicobacter pylori and length of stay in a nursing home
A Regev, G M Fraser, M Braun, et al.
Journal of Clinical Gastroenterology
|
December 17, 1998
A comparison of new rapid urease tests for detection of Helicobacter pylori: test characteristics and factors affecting positivity and time to positivity
Y Niv, A D Sperber, E Scapa, et al.
Alimentary Pharmacology & Therapeutics
|
November 28, 2008
Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms
P Rozen, Z Levi, R Hazazi, et al.
The American Journal of Gastroenterology
|
September 11, 1998
Comparison of two bowel preparations for colonoscopy: sodium picosulphate with magnesium citrate versus sulphate-free polyethylene glycol lavage solution
A Regev, G Fraser, G Delpre, et al.
Alimentary Pharmacology & Therapeutics
|
October 13, 2006
Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Z Levi, P Rozen, R Hazazi, et al.
Alimentary Pharmacology & Therapeutics
|
February 3, 2009
Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed
P Rozen, Z Levi, R Hazazi, et al.
Alimentary Pharmacology & Therapeutics
|
November 21, 2009
Can patients at high risk for significant colorectal neoplasms and having normal quantitative faecal occult blood test postpone elective colonoscopy?
R Hazazi, P Rozen, M Leshno, et al.
Page
of 2